SCR-LIP-000639 · Claim · machine-readable JSON →

Neuropathic pain features and peripheral nerve involvement, including neurogenic inflammation, are frequently reported in lipedema.

General proposition consolidated from 5 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
5 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20142026Pathophysiological dilemmas of lipedema — Szél et al. (2014) · consistentIndications of Peripheral Pain, Dermal Hypersensitivity, and Neurogenic Inflammation in Patients with Lipedema — Chakraborty et al. (2022) · consistentNeuropathic Pain Features in Lipedema Compared to Lymphedema: An Exploratory Cross-Sectional Study. — Pervane S, Uzun Ö. (2026) · consistentVascular and Nerve-Associated Inflammation in Lipedema Hand and Foot Tissue: A Case Report (2026) · consistentLipedema: pathophysiological insights and therapeutic strategies — An update for dermatologists (2026) · consistent

Evidence (5)

Context (PECO)

Population118 women with lipedema (n=62) or bilateral lower-extremity lymphedema (n=56)
Conditionlipedema
Exposurelipedema diagnosis
Comparatorlymphedema patients
Outcomeneuropathic pain features (painDETECT, LANSS), pain severity (VAS), anxiety/catastrophizing
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log